Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: David Botstein, Hugh Martin

Premium

Pacific Biosciences has named David Botstein to its board of directors.

Botstein is director of the Lewis-Sigler Institute for Integrative Genomics and Anthony B. Evnin Professor of Genomics at Princeton University, a position he has held since 2003. Prior to that, he was chairman of the department of genetics at Stanford University and before that he served as vice president for science at Genentech, where he currently serves on the company's scientific resource board.


Hugh Martin, former president and CEO of Pacific Biosciences, is now chairman and CEO of Xeralux, a manufacturer of LED retrofit kits. He joined the firm in April of this year.

Martin led PacBio from 2004 until January of this year, when he resigned and was replaced by Michael Hunkapiller. He resigned from the company's board in April.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.